SynthesisFrontiers in public health2026
Preexisting diabetes and gestational diabetes as risk factors for autism spectrum disorder: an umbrella review.
Synthesis in Frontiers in public health, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Maternal diabetes during pregnancy, including preexisting type 1 diabetes (T1DM), type 2 diabetes (T2DM), and gestational diabetes mellitus (GDM), has been investigated as a potential risk factor for autism spectrum disorder (ASD) in offspring. However, the consistency and strength of evidence across published meta-analyses remain uncertain. This umbrella review aimed to synthesize and critically appraise the existing meta-analytic evidence on this association. Methods: Following the PRISMA 2020 guidelines, we conducted an umbrella review of meta-analyses identified through PubMed, Web of Science, and Google Scholar from inception to March 31, 2026. Eligible studies quantitatively assessed the association between maternal diabetes and the risk of ASD. Of 636 records identified, 11 meta-analyses met the inclusion criteria. Data on effect estimates, heterogeneity, and potential bias were extracted. Study quality was assessed using AMSTAR 2, and overlap among primary studies was evaluated using the corrected covered area (CCA). Given the substantial overlap and methodological variability, the most robust meta-analysis for each exposure was prioritized, and findings were synthesized descriptively without conducting a Results: Across included meta-analyses, maternal diabetes was consistently associated with increased ASD risk in offspring. Preexisting diabetes showed a more consistent and stronger association compared with GDM, which also demonstrated a positive but more variable association. Heterogeneity was commonly moderate to high, and publication bias was variably reported. Overall evidence ranged from suggestive to weak, with higher credibility observed for preexisting diabetes than for GDM. Conclusion: A consistent and statistically significant association was observed between maternal diabetes-including both preexisting diabetes and GDM-and ASD, with evidence suggesting a risk gradient according to diabetes type. These findings highlight the importance of maternal metabolic health during pregnancy and support further research into the underlying mechanisms and potential preventive strategies. Systematic review registration: https://www.crd.york.ac.uk/PROSPERO/view/CRD420261334307, 2026CRD420261334307.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.